17
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      OX40 controls effector CD4 + T-cell expansion, not follicular T helper cell generation in acute Listeria infection

      research-article

      Read this article at

      Bookmark
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          To investigate the importance of OX40 signals for physiological CD4 + T-cell responses, an endogenous antigen-specific population of CD4 + T cells that recognise the 2W1S peptide was assessed and temporal control of OX40 signals was achieved using blocking or agonistic antibodies (Abs) in vivo. Following infection with Listeria monocytogenes expressing 2W1S peptide, OX40 was briefly expressed by the responding 2W1S-specific CD4 + T cells, but only on a subset that co-expressed effector cell markers. This population was specifically expanded by Ab-ligation of OX40 during priming, which also caused skewing of the memory response towards effector memory cells. Strikingly, this greatly enhanced effector response was accompanied by the loss of T follicular helper (TFH) cells and germinal centres. Mice deficient in OX40 and CD30 showed normal generation of TFH cells but impaired numbers of 2W1S-specific effector cells. OX40 was not expressed by 2W1S-specific memory cells, although it was rapidly up-regulated upon challenge whereupon Ab-ligation of OX40 specifically affected the effector subset. In summary, these data indicate that for CD4 + T cells, OX40 signals are important for generation of effector T cells rather than TFH cells in this response to acute bacterial infection.

          Related collections

          Most cited references22

          • Record: found
          • Abstract: found
          • Article: not found

          Control of immunity by the TNFR-related molecule OX40 (CD134).

          TNFR/TNF superfamily members can control diverse aspects of immune function. Research over the past 10 years has shown that one of the most important and prominent interactions in this family is that between OX40 (CD134) and its partner OX40L (CD252). These molecules strongly regulate conventional CD4 and CD8 T cells, and more recent data are highlighting their ability to modulate NKT cell and NK cell function as well as to mediate cross-talk with professional antigen-presenting cells and diverse cell types such as mast cells, smooth muscle cells, and endothelial cells. Additionally, OX40-OX40L interactions alter the differentiation and activity of regulatory T cells. Blocking OX40L has produced strong therapeutic effects in multiple animal models of autoimmune and inflammatory disease, and, in line with a prospective clinical future, reagents that stimulate OX40 signaling are showing promise as adjuvants for vaccination as well as for treatment of cancer.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            OX40 promotes Bcl-xL and Bcl-2 expression and is essential for long-term survival of CD4 T cells.

            It is important to understand which molecules are essential for long-lived immunity. We show that OX40 (CD134) is required with CD28 for the survival of CD4 T cells following antigen-driven expansion. In contrast to CD28-/- T cells, which show defects early, OX40-/- T cells are relatively unimpaired in IL-2 production, cell division, and expansion. However, OX40-/- T cells fail to maintain high levels of Bcl-xL and Bcl-2 4-8 days after activation, and undergo apoptosis. Conversely, OX40 stimulation promotes Bcl-xL and Bcl-2 and suppresses apoptosis. Moreover, retroviral transduction of OX40-/- T cells with Bcl-xL or Bcl-2 reverses their survival defect. Thus, a temporal relationship exists between CD28 and OX40, with OX40 being a critical regulator of antigen-driven T cell survival.
              Bookmark
              • Record: found
              • Abstract: found
              • Article: not found

              OX40 costimulation turns off Foxp3+ Tregs.

              OX40 is a recently identified T-cell costimulatory molecule that belongs to the TNF/TNFR superfamily. OX40 can be expressed by both activated T effector cells and Foxp3(+) Tregs. It is well known that OX40 delivers a potent costimulatory signal to T effector cells, but very little is known about the role of OX40 in regulating the suppressor properties of Foxp3(+) Tregs and the de novo generation of new inducible Foxp3(+) Tregs from T effector cells. In the present study, we found, by using a newly created foxp3gfp knockin model, that OX40 was dispensable for the genesis and suppressor functions of naturally arising CD4(+)Foxp3(+) Tregs, but stimulating OX40 on the Foxp3(+) Tregs abrogated their ability to suppress T effector cell proliferation, IFN-gamma production, and T effector cell-mediated allograft rejection. OX40 costimulation did not significantly affect proliferation and survival of the naturally arising Foxp3(+) Tregs, but profoundly inhibited Foxp3 gene expression. Importantly, OX40 costimulation to T effector cells prevented the induction of new inducible Foxp3(+) Tregs from T effector cells. Our study identified OX40 as a key negative regulator of Foxp3(+) Tregs and may have important clinical implications in models of transplantation and autoimmunity.
                Bookmark

                Author and article information

                Journal
                Eur J Immunol
                Eur. J. Immunol
                eji
                European Journal of Immunology
                BlackWell Publishing Ltd (Oxford, UK )
                0014-2980
                1521-4141
                August 2014
                21 May 2014
                : 44
                : 8
                : 2437-2447
                Affiliations
                [1 ]MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham Birmingham, United Kingdom
                [2 ]Babraham Institute, Babraham Research Campus Cambridge, United Kingdom
                [3 ]Department of Immunology, Juntendo University School of Medicine Tokyo, Japan
                Author notes
                Full correspondence Dr. David R. Withers, MRC Centre for Immune Regulation, College of Medical and Dental Sciences, University of Birmingham, Birmingham, B15 2TT, UK, Fax: +44(0)121-414-3599, e-mail: d.withers@ 123456bham.ac.uk

                Correspondence: Dr. David R. Withers e-mail: d.withers@ 123456bham.ac.uk

                Article
                10.1002/eji.201344211
                4285916
                24771127
                3e466a61-4ecd-4f31-a1a5-6d5dd9c2c747
                © 2014 The Authors. European Journal of Immunology published by WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim

                This is an open access article under the terms of the Creative Commons Attribution License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited.

                History
                : 25 October 2013
                : 25 March 2014
                : 25 April 2014
                Categories
                Immunomodulation

                Immunology
                cd4+ t cells,costimulation,germinal centre,memory,ox40
                Immunology
                cd4+ t cells, costimulation, germinal centre, memory, ox40

                Comments

                Comment on this article